Repligen Corporation

NASDAQ: RGEN · Real-Time Price · USD
127.22
0.58 (0.46%)
At close: Aug 15, 2025, 9:59 AM

Repligen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
634.44M 632.36M 801.54M 670.53M
Cost of Revenue
359.79M 323.54M 345.83M 279.28M
Gross Profit
274.64M 308.83M 455.71M 391.25M
Operating Income
-35.11M 47.7M 133.61M 133.5M
Interest Income
n/a n/a 6.98M 176K
Pretax Income
-27.04M 56.71M 219.14M 153.54M
Net Income
-25.51M 35.6M 185.96M 128.29M
Selling & General & Admin
263.37M 216.89M 215.83M 183.87M
Research & Development
43.2M 42.72M 43.94M 34.27M
Other Expenses
3.19M n/a n/a -1.17M
Operating Expenses
309.76M 261.12M 259.76M 218.14M
Interest Expense
22.57M 10.03M 2.98M 12.71M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
669.55M 584.66M 605.6M 497.42M
Income Tax Expense
-1.52M 21.11M 33.18M 25.25M
Shares Outstanding (Basic)
55.94M 55.72M 55.46M 55.02M
Shares Outstanding (Diluted)
55.94M 56.38M 57.45M 57.26M
EPS (Basic)
-0.46 0.64 3.35 2.33
EPS (Diluted)
-0.46 0.63 3.24 2.24
EBITDA
82.1M 127.77M 246.93M 211.56M
EBIT
-4.46M 59.21M 220.3M 164.82M
Depreciation & Amortization
86.56M 68.56M 50.98M 38.45M